Efficacy And Safety Of Glycopyrronium In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem1 Study

被引:0
|
作者
LaForce, C. [1 ]
Pearle, J. [2 ]
Feldman, G. [3 ]
Spangenthal, S. [4 ]
Eckert, J. H. [5 ]
Mota, F. [5 ]
Henley, M. [6 ]
D'Andrea, P. [6 ]
机构
[1] North Carolina Clin Res, Raleigh, NC USA
[2] Calif Res Med Grp Inc, Fullerton, CA USA
[3] S Carolina Pharmaceut Res, Spartanburg, SC USA
[4] Amer Hlth Res Charlotte, Charlotte, NC USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5745
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Hand Grip Strength and Likelihood of Moderate-to-Severe Airflow Limitation in the General Population
    Kim, Sunyoung
    Yoon, Hyoung Kyu
    Rhee, Chin Kook
    Jung, Hee-Won
    Lee, Hyun
    Jo, Yong Suk
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 1237 - 1245
  • [32] Seebri™ Neohaler® (Glycopyrrolate) Versus Placebo in Patients with Moderate to Severe COPD: Analysis of Health-Related Quality of Life (HRQoL) from the GEM1 Study
    Feldman, G.
    Dembek, C.
    Rajagopalan, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
    Anthony D'Urzo
    Gary T Ferguson
    Jan A van Noord
    Kazuto Hirata
    Carmen Martin
    Rachael Horton
    Yimeng Lu
    Donald Banerji
    Tim Overend
    Respiratory Research, 12
  • [34] Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
    D'Urzo, Anthony
    Ferguson, Gary T.
    van Noord, Jan A.
    Hirata, Kazuto
    Martin, Carmen
    Horton, Rachael
    Lu, Yimeng
    Banerji, Donald
    Overend, Tim
    RESPIRATORY RESEARCH, 2011, 12
  • [35] Safety and Efficacy of 12-Week or Longer Indacaterol Treatment in Moderate-to-Severe COPD Patients: A Systematic Review
    Jiang, Fa-Ming
    Liang, Zong-An
    Zheng, Qiao-Ling
    Wang, Rong-Chun
    Luo, Jian
    Li, Chun-Tao
    LUNG, 2013, 191 (02) : 135 - 146
  • [36] Safety and Efficacy of 12-Week or Longer Indacaterol Treatment in Moderate-to-Severe COPD Patients: A Systematic Review
    Fa-Ming Jiang
    Zong-An Liang
    Qiao-Ling Zheng
    Rong-Chun Wang
    Jian Luo
    Chun-Tao Li
    Lung, 2013, 191 : 135 - 146
  • [37] Efficacy and Safety of Ixekizumab in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis
    Paller, Amy
    Seyger, Marieke
    Alejandro Magarinos, Gabriel
    Bagel, Jerry
    Keller, Stuart
    Capriles, Claudia Rodriguez
    Gallo, Gaia
    Edson-Heredia, Emily
    Li, Lingnan
    Xu, Wen
    Papp, Kim
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 17 - 17
  • [38] Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study
    Wang, Chen
    Sun, Tieying
    Huang, Yijiang
    Humphries, Michael
    Bai, Lingyan
    Li, Lilly
    Wang, Qian
    Kho, Pearl
    Firth, Roz
    D'Andrea, Peter
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 57 - 68
  • [39] Efficacy and Safety of Dupilumab in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: Phase 3 NOTUS Trial
    Bhatt, S. P.
    Rabe, K. F.
    Hanania, N. A.
    Vogelmeier, C. F.
    Bafadhel, M.
    Christenson, S. A.
    Papi, A.
    Singh, D.
    Laws, E.
    Akinlade, B.
    Maloney, J.
    Lu, X.
    Bauer, D.
    Bansal, A.
    Abdulai, R. M.
    Robinson, L. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [40] Dupilumab efficacy and safety in patients with moderate-to-severe COPD with type 2 inflammation: pooled analysis of BOREAS and NOTUS
    Bhatt, Surya
    Rabe, Klaus F.
    Hanania, Nicola
    Vogelmeier, Claus F.
    Bafadhel, Mona
    Christenson, Stephanie
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Akinlade, Bolanle
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Abdulai, Raolat M.
    Robinson, Lacey B.
    Bhatt, Surya
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64